Giselle L Saulnier Sholler MD MSc
Director. ISF Solid and Rare Tumor Program Chair, Beat Childhood Cancer Research Consortium Division chief of Pediatric Hematology and Oncology at Penn State Health Children’s Hospital. Director of pediatric oncology research at Penn State College of Medicine.
Dr. Saulnier Sholler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Rhode Island Hospital/Brown University HealthFellowship, Pediatric Hematology/Oncology, 2002 - 2005
- Brown UniversityResidency, Pediatrics, 1999 - 2002
- New York Medical CollegeClass of 1999
Certifications & Licensure
- PA State Medical License 2023 - 2026
- NC State Medical License 2020 - 2024
- MI State Medical License 2011 - 2021
- VT State Medical License 2005 - 2012
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 3 citationsA pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.Jacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld
Cancer Reports. 2022-11-01 - 1 citationsDevelopment of Clinical-Grade Antibodies against Tumor-Specific Mutations to Target Neuroblastoma.Stephanie C Pero, Abhinav B Nagulapally, Linda Mei, Fan Zhang, Giselle S Sholler
Annals of Clinical and Laboratory Science. 2022-05-01 - 3 citationsIdentification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma.Maximillian S Westphal, Eunjee Lee, Eric E Schadt, Giselle S Sholler, Jun Zhu
Cancers. 2021-12-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: